Metagenomi (MGX) announced that Eric Bjerkholt, CFO of Mirum Pharmaceuticals (MIRM), will join Metagenomi’s Board of Directors, serving on Metagenomi’s Audit and Compensation committees, effective January 27, 2025.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MGX:
- Metagenomi price target raised to $14 from $7 at H.C. Wainwright
- Metagenomi presents updated preclinical NHP data at ASH meeting
- Metagenomi presents updated preclinical data in Hemophilia A at ASH
- Jefferies Predicts Up to ~1000% Surge for These 2 ‘Strong Buy’ Stocks
- Class Action Lawsuit Against Metagenomi Inc. (NASDAQ:MGX)